The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare's most fundamental tools.
a clinical-stage company developing medical devices from innovative biomaterials, today announced the initiation of the EMBO-02 clinical study of NeoCast™ to treat chronic subdural hematomas (cSDH).